PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
NCT02382016
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Portopulmonary Hypertension
Interventions
DRUG:
Macitentan
OTHER:
Placebo
Sponsor
Actelion